Onconetix, Inc.
ONCO
$0.51
-$0.01-1.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -67.70% | -34.58% | -9.34% | 153.70% | 4,214.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -67.70% | -34.58% | -9.34% | 153.70% | 4,214.70% |
| Cost of Revenue | -87.58% | -93.14% | -80.65% | -40.29% | 23.90% |
| Gross Profit | -40.02% | 242.77% | 205.28% | 197.20% | 193.60% |
| SG&A Expenses | -37.29% | -45.64% | -49.15% | -45.23% | -23.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.30% | -53.05% | -53.02% | -46.71% | -28.21% |
| Operating Income | 38.59% | 55.25% | 56.66% | 54.89% | 42.11% |
| Income Before Tax | 76.51% | 3.26% | 15.13% | -24.50% | -59.63% |
| Income Tax Expenses | 100.05% | -556.65% | -1,068.35% | -588.23% | -8,195.24% |
| Earnings from Continuing Operations | 76.09% | 4.77% | 16.83% | -22.85% | -56.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.09% | 4.77% | 16.83% | -22.85% | -56.89% |
| EBIT | 38.59% | 55.25% | 56.66% | 54.89% | 42.11% |
| EBITDA | 34.06% | 54.18% | 57.46% | 57.17% | 46.08% |
| EPS Basic | 90.98% | -39.27% | -- | -- | -- |
| Normalized Basic EPS | 96.17% | 89.23% | -- | -- | -- |
| EPS Diluted | 90.98% | -39.27% | -- | -- | -- |
| Normalized Diluted EPS | 96.17% | 89.23% | -- | -- | -- |
| Average Basic Shares Outstanding | 3,130.66% | 14,724.68% | -- | -- | -- |
| Average Diluted Shares Outstanding | 3,130.66% | 14,724.68% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |